Literature DB >> 15009185

Functional analyses of placental protein 13/galectin-13.

Nandor G Than1, Elah Pick, Szabolcs Bellyei, Andras Szigeti, Ora Burger, Zoltan Berente, Tamas Janaky, Arpad Boronkai, Harvey Kliman, Hamutal Meiri, Hans Bohn, Gabor N Than, Balazs Sumegi.   

Abstract

Placental protein 13 (PP13) was cloned from human term placenta. As sequence analyses, alignments and computational modelling showed its conserved structural and functional homology to members of the galectin family, the protein was designated galectin-13. Similar to human eosinophil Charcot-Leyden crystal protein/galectin-10 but not other galectins, its weak lysophospholipase activity was confirmed by 31P-NMR. In this study, recombinant PP13/galectin-13 was expressed and specific monoclonal antibody to PP13 was developed. Endogenous lysophospholipase activity of both the purified and also the recombinant protein was verified. Sugar binding assays revealed that N-acetyl-lactosamine, mannose and N-acetyl-glucosamine residues widely expressed in human placenta had the strongest binding affinity to both the purified and recombinant PP13/galectin-13, which also effectively agglutinated erythrocytes. The protein was found to be a homodimer of 16 kDa subunits linked together by disulphide bonds, a phenomenon differing from the noncovalent dimerization of previously known prototype galectins. Furthermore, reducing agents were shown to decrease its sugar binding activity and abolish its haemagglutination. Phosphorylation sites were computed on PP13/galectin-13, and phosphorylation of the purified protein was confirmed. Using affinity chromatography, PAGE, MALDI-TOF MS and post source decay, annexin II and beta/gamma actin were identified as proteins specifically bound to PP13/galectin-13 in placenta and fetal hepatic cells. Perinuclear staining of the syncytiotrophoblasts showed its expression in these cells, while strong labelling of the syncytiotrophoblasts' brush border membrane confirmed its galectin-like externalization to the cell surface. Knowing its colocalization and specific binding to annexin II, PP13/galectin-13 was assumed to be secreted to the outer cell surface by ectocytosis, in microvesicles containing actin and annexin II. With regard to our functional and immunomorphological results, PP13/galectin-13 may have special haemostatic and immunobiological functions at the lining of the common feto-maternal blood-spaces or developmental role in the placenta.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15009185     DOI: 10.1111/j.1432-1033.2004.04004.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  44 in total

Review 1.  Towards molecular mechanisms regulating the expression of galectins in cancer cells under microenvironmental stress conditions.

Authors:  Alexander V Timoshenko
Journal:  Cell Mol Life Sci       Date:  2015-08-06       Impact factor: 9.261

2.  Embryo-placento-maternal interaction and biomarkers: from diagnosis to therapy--a workshop report.

Authors:  N G Than; M J Paidas; S Mizutani; S Sharma; J Padbury; E R Barnea
Journal:  Placenta       Date:  2007-03-23       Impact factor: 3.481

3.  Establishment of human trophoblast progenitor cell lines from the chorion.

Authors:  Olga Genbacev; Matthew Donne; Mirhan Kapidzic; Matthew Gormley; Julie Lamb; Jacqueline Gilmore; Nicholas Larocque; Gabriel Goldfien; Tamara Zdravkovic; Michael T McMaster; Susan J Fisher
Journal:  Stem Cells       Date:  2011-09       Impact factor: 6.277

4.  A primate subfamily of galectins expressed at the maternal-fetal interface that promote immune cell death.

Authors:  Nandor Gabor Than; Roberto Romero; Morris Goodman; Amy Weckle; Jun Xing; Zhong Dong; Yi Xu; Federica Tarquini; Andras Szilagyi; Peter Gal; Zhuocheng Hou; Adi L Tarca; Chong Jai Kim; Jung-Sun Kim; Saied Haidarian; Monica Uddin; Hans Bohn; Kurt Benirschke; Joaquin Santolaya-Forgas; Lawrence I Grossman; Offer Erez; Sonia S Hassan; Peter Zavodszky; Zoltan Papp; Derek E Wildman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-02       Impact factor: 11.205

5.  Evolutionary origins of the placental expression of chromosome 19 cluster galectins and their complex dysregulation in preeclampsia.

Authors:  N G Than; R Romero; Y Xu; O Erez; Z Xu; G Bhatti; R Leavitt; T H Chung; H El-Azzamy; C LaJeunesse; B Wang; A Balogh; G Szalai; S Land; Z Dong; S S Hassan; T Chaiworapongsa; M Krispin; C J Kim; A L Tarca; Z Papp; H Bohn
Journal:  Placenta       Date:  2014-08-26       Impact factor: 3.481

6.  Allosteric regulation of the carbohydrate-binding ability of a novel conger eel galectin by D-mannoside.

Authors:  Mizuki Watanabe; Osamu Nakamura; Koji Muramoto; Tomohisa Ogawa
Journal:  J Biol Chem       Date:  2012-07-18       Impact factor: 5.157

Review 7.  A potential pathophysiological role for galectins and the renin-angiotensin system in preeclampsia.

Authors:  Sandra M Blois; Ralf Dechend; Gabriela Barrientos; Anne Cathrine Staff
Journal:  Cell Mol Life Sci       Date:  2014-09-06       Impact factor: 9.261

Review 8.  Human trophoblast progenitors: where do they reside?

Authors:  Olga Genbacev; Julie D Lamb; Akraporn Prakobphol; Matt Donne; Michael T McMaster; Susan J Fisher
Journal:  Semin Reprod Med       Date:  2013-01-17       Impact factor: 1.303

9.  Proteomic identification of Placental Protein 1 (PP1), PP8, and PP22 and characterization of their placental expression in healthy pregnancies and in preeclampsia.

Authors:  Szilvia Szabo; Katalin Karaszi; Roberto Romero; Eszter Toth; Andras Szilagyi; Zsolt Gelencser; Yi Xu; Andrea Balogh; Gabor Szalai; Petronella Hupuczi; Beata Hargitai; Tibor Krenacs; Eva Hunyadi-Gulyas; Zsuzsanna Darula; Katalin A Kekesi; Adi L Tarca; Offer Erez; Gabor Juhasz; Ilona Kovalszky; Zoltan Papp; Nandor Gabor Than
Journal:  Placenta       Date:  2020-06-22       Impact factor: 3.481

Review 10.  Potential markers of preeclampsia--a review.

Authors:  Simon Grill; Corinne Rusterholz; Rosanna Zanetti-Dällenbach; Sevgi Tercanli; Wolfgang Holzgreve; Sinuhe Hahn; Olav Lapaire
Journal:  Reprod Biol Endocrinol       Date:  2009-07-14       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.